Flavio Solca
37Patents
20h-index
46Co-inventors
81Inventor score
Filing activity: Feb 24, 2000 → Jun 1, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6861422B2 | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions | Chemistry; Metallurgy | 65 | Expired |
| US6627634B2 | Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them | Chemistry; Metallurgy | 61 | Expired |
| US6740651B2 | Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases | Human Necessities | 53 | Expired |
| US7220750B2 | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them | Chemistry; Metallurgy | 50 | Expired |
| US6653305B2 | Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them | Chemistry; Metallurgy | 50 | Expired |
| US6656946B2 | Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases | Chemistry; Metallurgy | 45 | Expired |
| US6403580B1 | Quinazolines, pharmaceutical compositions containing these compounds, their use and processes for preparing them | Chemistry; Metallurgy | 41 | Expired |
| US7241889B2 | 6-formyl-tetrahydropteridines, process for their manufacture and use thereof as medicaments | Human Necessities | 38 | Expired |
| US6972288B1 | 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases | Chemistry; Metallurgy | 38 | Expired |
| US7750152B2 | Intermediate compounds for making dihydropteridinones useful as pharmaceutical compositions and processes of making the same | Chemistry; Metallurgy | 37 | Active |
| US7332491B2 | Dihydropteridione derivatives, process for their manufacture and their use as medicament | Emerging Cross-Sectional Technologies | 33 | Expired |
| US6617329B2 | Aminoquinazolines and their use as medicaments | Chemistry; Metallurgy | 33 | Expired |
| US6924285B2 | Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them | Chemistry; Metallurgy | 32 | Expired |
| US7846936B2 | Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis | Human Necessities | 30 | Active |
| US8003786B2 | Dihydropteridinone compounds | Chemistry; Metallurgy | 30 | Active |
| US7019012B2 | Quinazoline derivatives and pharmaceutical compositions containing them | Chemistry; Metallurgy | 29 | Expired |
| US7119084B2 | Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them | Chemistry; Metallurgy | 29 | Expired |
| US7414053B2 | Dihydropteridione derivatives, process for their manufacture and their use as medicament | Emerging Cross-Sectional Technologies | 27 | Expired |
| USRE43431E1 | Quinazoline derivatives and pharmaceutical compositions containing them | General | 25 | Active |
| US7759347B2 | 2-benzylaminodihydropteridinones, process for their manufacture and use thereof as medicaments | Human Necessities | 21 | Active |
| US7786299B2 | Methods for treating diseases or conditions using dihydropteridinone compounds | Chemistry; Metallurgy | 19 | Expired |
| US7521457B2 | Pyrimidines as PLK inhibitors | Chemistry; Metallurgy | 18 | Expired |
| US7223749B2 | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them | Chemistry; Metallurgy | 17 | Expired |
| US8404697B2 | Quinazoline derivatives for the treatment of cancer diseases | Human Necessities | 13 | Active |
| US7569561B2 | 2,4-diaminopyrimidines useful for treating cell proliferation diseases | Chemistry; Metallurgy | 11 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.